RBM19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.631800E-01
Normal-vs-Stage2
1.174780E-01
Normal-vs-Stage3
9.985900E-02
Normal-vs-Stage4
3.034600E-01
Stage1-vs-Stage2
3.428600E-01
Stage1-vs-Stage3
1.557020E-01
Stage1-vs-Stage4
5.908400E-01
Stage2-vs-Stage3
5.573900E-02
Stage2-vs-Stage4
8.942800E-01
Stage3-vs-Stage4
1.115840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.749800E-01
Normal-vs-AfricanAmerican
1.525390E-01
Normal-vs-Asian
6.091800E-02
Caucasian-vs-AfricanAmerican
4.333800E-01
Caucasian-vs-Asian
1.129400E-01
AfricanAmerican-vs-Asian
6.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.414810E-01
Normal-vs-Female
3.132800E-01
Male-vs-Female
8.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.827000E-01
Normal-vs-Age(41-60Yrs)
4.964600E-01
Normal-vs-Age(61-80Yrs)
2.575400E-01
Normal-vs-Age(81-100Yrs)
4.911200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.860400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.444200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.792400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.393600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.244800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.111390E-01
Normal-vs-Daily Drinker
2.087600E-01
Normal-vs-Weekly Drinker
2.851600E-01
Normal-vs-Occasional Drinker
9.250200E-01
Normal-vs-Social Drinker
5.253400E-01
Non Drinker-vs-Daily Drinker
4.442400E-01
Non Drinker-vs-Weekly Drinker
6.660200E-01
Non Drinker-vs-Occasional Drinker
1.297980E-01
Non Drinker-vs-Social Drinker
2.453200E-01
Daily Drinker-vs-Weekly Drinker
8.619400E-01
Daily Drinker-vs-Occasional Drinker
2.471000E-01
Daily Drinker-vs-Social Drinker
6.787800E-01
Weekly Drinker-vs-Occasional Drinker
2.421000E-01
Weekly Drinker-vs-Social Drinker
6.181600E-01
Occasional Drinker-vs-Social Drinker
3.245200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.109600E-01
Normal-vs-Grade 2
8.294200E-01
Normal-vs-Grade 3
8.082800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.862200E-01
Grade 1-vs-Grade 3
6.101000E-01
Grade 1-vs-Grade 4
6.109600E-01
Grade 2-vs-Grade 3
5.868200E-01
Grade 2-vs-Grade 4
8.294200E-01
Grade 3-vs-Grade 4
8.082800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.224400E-01
Normal-vs-NonDiabetic
2.775000E-01
Diabetic-vs-NonDiabetic
7.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.126600E-01
Normal-vs-NoPancreatitis
2.765000E-01
Pancreatitis-vs-NoPancreatitis
9.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.761600E-01
Normal-vs-N1
9.767600E-02
N0-vs-N1
3.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.790400E-02
Normal-vs-TP53-NonMutant
4.356800E-01
TP53-Mutant-vs-TP53-NonMutant
1.930020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
